Department of Biochemistry and Molecular
Biology, Louisiana State University Health Sciences Center,
Shreveport, Louisiana 71130
Received 23 February 2000/Returned for modification 4 April
2000/Accepted 16 May 2000
In the nucleus, transcription factors must contend with the
presence of chromatin in order to gain access to their cognate regulatory sequences. As most nuclear DNA is assembled into
nucleosomes, activators must either invade a stable, preassembled
nucleosome or preempt the formation of nucleosomes on newly replicated
DNA, which is transiently free of histones. We have investigated the mechanism by which heat shock factor (HSF) binds to target nucleosomal heat shock elements (HSEs), using as our model a dinucleosomal heat
shock promoter (hsp82-
HSE1). We find that activated HSF cannot bind a stable, sequence-positioned nucleosome in
G1-arrested cells. It can do so readily, however, following
release from G1 arrest or after the imposition of either an
early S- or late G2-phase arrest. Surprisingly, despite the
S-phase requirement, HSF nucleosomal binding activity is restored in
the absence of hsp82 replication. These results contrast
with the prevailing paradigm for activator-nucleosome interactions and
implicate a nonreplicative, S-phase-specific event as a prerequisite
for HSF binding to nucleosomal sites in vivo.
 |
INTRODUCTION |
In the eukaryotic cell, nuclear DNA
is packaged into a compact structure known as chromatin, a complex of
DNA and histone proteins. The packaging of DNA into chromatin not only
serves to confine the genome within the boundaries of the nucleus but also regulates the transcriptional activation of genes. The presence of
nucleosomes, the individual subunits of chromatin, can inhibit the
binding of sequence-specific activators to upstream elements, as well
as impede access of the general transcription machinery to the core
promoter (reviewed in reference 35). As a
consequence, nucleosomes inhibit transcription, both in vitro (34,
43, 72) and in vivo (27, 29, 61). Thus, an important
function of activators is to overcome nucleosomal repression, either by blocking nucleosome formation over promoters, thereby presetting genes
for activation, or by remodeling preassembled nucleosomes as the
initial step in transcriptional activation.
The mechanisms by which activators recognize and bind their cognate
sites within chromatin are varied. Certain factors, like NF-1 and GCN4,
can access their sites only within nuclease-hypersensitive, nucleosome-rearranged regions (5, 15, 66, 75). Others, such
as PHO4, bind to accessible regions but, once DNA bound, actively
remodel neighboring nucleosomes (1, 19). Still others are
capable of invading a stable nucleosome and binding to target sites
wrapped around the nucleosome core. Glucocorticoid receptor, for
example, invades a sequence-positioned nucleosome within the mouse
mammary tumor virus promoter following exposure to hormone (5). Receptor binding to its cognate sequence leads to a
dramatic reconfiguring of the underlying nucleosome (66) and
occurs in the absence of replication (55). The ability of
activators to invade a preassembled nucleosome may require the
involvement of ATP-dependent chromatin remodeling complexes and/or
histone acetyltransferases (reviewed in references 36, 62,
71, and 73). Alternatively, gene-specific
activators may access nucleosomal binding sites by preempting the
formation of nucleosomes following DNA replication (63).
This could occur either by outcompeting histones for binding to newly
replicated DNA or by aborting the maturation of a nascent nucleosome. A
requirement for DNA replication in gene activation in vitro has been
described (7, 33); however, no evidence exists for
replication-dependent binding of an activator to a defined nucleosomal
site in vivo.
In this study, we used the Saccharomyces cerevisiae HSP82
heat shock gene to investigate transcription factor binding to
nucleosomal DNA in vivo. Previous work has shown that the wild-type
(WT) promoter is maintained in a DNase I-hypersensitive,
nucleosome-disrupted state (24, 64). Within this accessible
region, heat shock transcription factor (HSF) constitutively binds to a
high-affinity heat shock element, HSE1, and inducibly and cooperatively
to two low-affinity sites, HSE2 and HSE3 (18, 23, 25). The
TATA element is also constitutively occupied (25, 56). In a
promoter mutant lacking HSE1, termed hsp82-
HSE1, all
detectable sequence-specific interactions are abolished (summarized in
Fig. 1) and are replaced by two stable,
sequence-positioned nucleosomes. One nucleosome (termed Nuc
2) is
centered over the mutated heat shock upstream activation sequence (UAS;
comprising HSE2 and HSE3), while the other, Nuc
1, is centered over
the TATA initiation site (24). This striking phenotype
suggests that the open chromatin structure and transcriptional
competence of the WT promoter are maintained by HSF. Consistent with
this notion, the protein can act as a high-copy suppressor of
hsp82-
HSE1. Its ability to activate transcription is
obviated by deletion of HSE2 and HSE3, indicating that suppression is
mediated through these elements (24). In the present study, we address the mechanism by which HSF binds nucleosomal DNA. In theory,
HSF could access its sites by directly invading the preassembled nucleosome (disruption mechanism), by aborting the maturation of a
nascent nucleosome (preempt mechanism), or by outcompeting histones at
the replication fork (exclusion mechanism). We show here that HSF is
incapable of binding nucleosomal HSEs in G1-arrested cells.
However, the activated factor can gain access to such sites following
release of cells from the G1 block, or after imposition of
an early S-phase arrest, and does so in the absence of DNA replication.
It also readily binds nucleosomal DNA in cells prearrested in
G2/M. This represents, to our knowledge, the first example of cell cycle-specific binding by an activator to a defined nucleosomal site.

View larger version (17K):
[in this window]
[in a new window]
|
FIG. 1.
Principal HSP82 regulatory elements, their
state of occupancy in vivo, and associated transcript levels. The
HSE1 mutation consists of a 32-bp deletion of HSE1 and flanking
sequence (24). The HSE1 · 4 promoter bears two
mutations: a 32-bp substitution of HSE1 for PET56 coding
sequence, and a 72-bp deletion of HSE4. +1, principal transcription
start site. mRNA expression levels represent the means of at least
three independent experiments. Occupancy data are summarized from work
described here and elsewhere (18, 23-25, 46, 56).
|
|
 |
MATERIALS AND METHODS |
Yeast strains and plasmids.
Strain CBY106 was constructed by
two-step gene transplacement of the
hsp82
::CYH2s disruption
strain SLY102 (40) (Table 1).
The transforming DNA fragment, bearing a 32-bp substitution of HSE1
(
187 to
155) with PET56 coding sequence (24)
and a 72-bp deletion of HSE4 (
673 to
612) was constructed by PCR
overlap extension and cloned into the URA3 integrating
vector, pRS306. Targeting of the hsp82 locus was achieved by
linearizing the resultant construct (pCB107) at the unique
AvaI site (
914) within HSP82. Gene
transplacement was verified by genomic PCR. The BAR1 gene
was disrupted by a one-step gene transplacement using the 5.5-kb
bar1
::LEU2 fragment excised from
pZV77 (gift from D. Hagen and G. Sprague). Plasmid pGAL1-HSF
(URA3), bearing the PvuII-XhoI
fragment of yeast HSF1 under regulation of the
GAL1 promoter (gift from P. Sorger), was transformed into
strains BSY202 and CBY106, creating CBY101 and CBY107, respectively.
Site-directed integration of a TRP1-Kanr
reporter (flanked by directly repeated R sites) into chromosome V (6.6 kb upstream of KHS1 and 2.8 kb downstream of
ISC10 [45]) was achieved by transforming
BSY202 with StuI-linearized p252-KT-DIR (gift from M. K. Raghuraman and W. Fangman). Note that this segment of DNA contains
no sequence that can function as an origin of replication in S. cerevisiae (21). An episomal GAL1-regulated R-recombinase gene (YCpG-RURA) from Zygosaccharomyces rouxii
was subsequently introduced into this strain, creating CBY120.
Cultivation and cell cycle arrest conditions.
Yeast strains
were grown at 30°C in synthetic complete medium lacking uracil and
containing 2% raffinose to ~107 cells/ml (determined by
cell counting). To effect a G1 arrest,
-factor was added
to a final concentration of 500 ng/ml. Strains used in this study were
supersensitive to
-factor since they were deleted for
BAR1, which encodes a secreted protease that degrades the
pheromone. Cultures were incubated in the presence of
-factor for at
least 2.5 h at 30°C and then examined by microscopy. When the
fraction of shmoos exceeded 95%, an aliquot was removed for RNA
analysis (noninduced) directly or following a 15-min, 39°C heat shock
(induced). Galactose was then added to a final concentration of 1%,
and samples were similarly collected at various time points thereafter.
Heat shocks were achieved by adding an equivalent volume of prewarmed
(51°C) medium to the culture, resulting in an instantaneous
30
39°C upshift. To effect an arrest in early S phase, hydroxyurea
(HU) was added to early log cultures at a final concentration of 200 mM. Cultures were then incubated with shaking for 2.5 to 3 h at
30°C. When 90% of cells contained large buds, cultures were
subjected to a galactose shift as described above. To effect an arrest
in G2/M, nocodazole (1 mg/ml dissolved in dimethyl
sulfoxide [DMSO]) was added to a final concentration of 10 µg/ml,
and cells were incubated for 3.5 to 4.0 h prior to addition of
galactose, at which time >95% of the cells contained large buds. In
all cases, cell density remained constant for the duration of the
arrest. Occasionally, asynchronous controls were diluted to maintain a
cell density of 107 to 2 × 107 cells/ml.
There was no difference in heat shock-induced transcript levels between
asynchronous cultures that were diluted and those that were not. To
ascertain cellular DNA content, culture aliquots were removed, fixed in
70% ethanol, stained with propidium iodide, and subjected to FACS
(fluorescence-activated cell sorting) analysis using a Becton Dickinson
(San Jose, Calif.) FACS Calibur. HU arrest was confirmed by a
broadening of the 1N peak and a suppression of the 2N peak.
Blot hybridization.
For Northern blots total RNA was
isolated, electrophoresed, blotted, and hybridized as described
elsewhere (18). HSP82 and HSP26 mRNA
levels, internally normalized with respect to ACT1, were
quantitated using a PhosphorImager. For Southern blots, genomic DNA was
isolated by glass bead lysis (30), digested with
EcoO109I, and deproteinized; then 1.5 µg of DNA was
applied to a 1% agarose-1× Tris-borate-EDTA gel. Following alkaline
transfer and UV cross-linking to GeneScreen, hybridization was
conducted at 65°C with the following gene-specific probes: a
250-nucleotide (nt) riboprobe (p5L) spanning
1300 to
1049 of
HSP82 (24); a 1.4-kb PCR fragment spanning Kanr; and a 0.4-kb PCR fragment that hybridizes
to a region immediately downstream of KEX2.
MNase genomic footprinting.
Cells were cultivated at 30°C
to mid-log phase in 500 ml of YPD, metabolically poisoned through
addition of sodium azide to 20 mM, harvested, and washed in 50 ml of
ice-cold TA buffer (20 mM Tris-HCl [pH 8.0], 20 mM sodium azide).
They were then resuspended in 5 ml of spheroplast buffer (1.4 M
sorbitol, 40 mM HEPES [pH 7.5], 0.5 mM MgCl2, 0.5%
2-mercaptoethanol, 20 mM NaN3, 1 mM phenylmethylsulfonyl [PMSF], 2 mM N-ethylmaleimide, 2 mM benzamidine). Lyticase
(2.5 mg/g of cells) was added, and spheroplasting proceeded for 30 to
60 min at 30°C with mild agitation. Spheroplasts were harvested and
resuspended in 10 ml of ice-cold 18% Ficoll buffer (18% Ficoll, 20 mM
PIPES [pH 6.5], 0.5 mM MgCl2, 1 mM PMSF, 2 mM
N-ethylmaleimide, 2 mM benzamidine). Nuclei were isolated by
layering the spheroplast suspension on top of 15 ml of ice-cold
glycerol-Ficoll buffer (7% Ficoll, 20% glycerol, 20 mM PIPES [pH
6.5], 0.5 mM MgCl2, 1 mM PMSF, 2 mM
N-ethylmaleimide, 2 mM benzamidine) and centrifuged at
12,500 rpm in a Sorvall HB-4 swinging bucket rotor for 30 min. Nuclear
pellets were resuspended in 1 ml of micrococcal nuclease (MNase)
digestion buffer (40 mM HEPES [pH 7.5], 1 mM MgCl2, 1 mM
CaCl2, 1 mM PMSF, 2 mM N-ethylmaleimide, 2 mM
benzamidine) and divided into five equal aliquots. To each aliquot was
added 15, 30, 60, 120, or 240 U of MNase (Pharmacia Biotech product no.
27-0584-01). Nuclei were digested for 10 min at room temperature; digestions were terminated by the addition of an equal volume of stop
buffer (2% sodium dodecyl sulfate [SDS], 1 M NaCl, 50 mM EDTA, 50 mM
Tris [pH 7.5]). Digestion of naked DNA was accomplished by reacting 2 µg of DNA with 6 × 10
4 U of MNase in 500 µl of
1 mM CaCl2-1 mM MgCl2-40 mM HEPES (pH 7.5).
This digestion was conducted at room temperature for 5 min and
terminated by the addition of EDTA to 10 mM. DNA samples were purified
as described elsewhere (17). HSP82-specific
cleavages were detected by linear PCR using both upper- and
lower-strand complementary primers (+26
11 and
342
315,
respectively). Bands were detected on a PhosphorImager, and their
intensities were quantitated (in terms of peak amplitudes) on a
Macintosh G3 using ImageQuant 1.1.
DMS in vivo footprinting.
Cells were grown in raffinose
Ura-deficient medium to a density of ~107 cells/ml and
subjected to cell cycle arrest and heat shock as described above.
Samples were treated with a final concentration of either 0.4 or 0.8%
dimethyl sulfate (DMS) for 2 min, with rapid agitation at 39°C.
Reactions were terminated, DNA was isolated, and linear PCR was
conducted using the upper-strand complementary primer +26
11 as
previously described (56).
Restriction enzyme accessibility assay.
Cells were grown in
raffinose complete medium to a density of 107 cells/ml and
subjected to cell cycle arrest as described above. Nuclei were isolated
and digested at 30°C for 1 h using 12, 40, or 100 U of
HindIII per µg of DNA. The amount of DNA in each
sample was measured spectrophotometrically prior to addition of enzyme. A 5-µl aliquot of nuclear suspension was added to 495 µl of 1 N
NaOH, and DNA concentration was estimated by using the formula (A260
1.6 × A320)/27 (17). Purified genomic DNA
was digested to completion with MspI and subjected to linear
PCR using the upper-strand complementary primer +26
11.
Protein isolation and Western analysis.
Immunoblot analysis
was performed using total protein from whole-cell extracts, obtained by
breaking cells with glass beads in the presence of 5% trichloroacetic
acid. Proteins were pelleted and resuspended in 6 M urea buffer
(14), then electrophoresed on an SDS-10% polyacrylamide
gel, blotted to nitrocellulose, and sequentially probed with polyclonal
rabbit antisera raised against either glutathione
S-transferase-HSF (17) or Leu4p (gift from Gunter Kohlhaw, Purdue University). Horseradish peroxidase-conjugated goat anti-rabbit antibody (Amersham) was then added, and the secondary antibody was detected either by autoradiography using enhanced chemiluminescence (ECL; Amersham) or by PhosphorImager using ECL Plus.
 |
RESULTS |
The hsp82-
HSE1 promoter assembles into a
dinucleosome in vivo.
Our previous work has shown that the
nucleosome centered over the core promoter of hsp82-
HSE1,
termed Nuc
1, is rotationally phased (24). However, its
translational position and that of the adjacent, UAS-containing
nucleosome (Nuc
2) are less well characterized. Such information is
important, since accessibility of a binding site decreases as it is
moved from the edge to the center (dyad) of a nucleosome core
(58). Therefore, the most rigorous test of HSF's nucleosome
binding activity will be presented if the target HSEs are proximate to
the dyad. To determine the translational setting of these nucleosomes,
we digested purified nuclei with MNase and mapped cleavage sites at
nucleotide resolution using linear PCR (18). As illustrated
in the genomic footprints of Fig.
2A, the
heat shock UAS of the WT allele, defined as sequence lying between
235 and
150 (18), is accessible to MNase. This accessibility is evident on both strands and culminates in a series of
intense cleavages centered at positions
112 and
111. The cutting
pattern is specific to chromatin and argues against the presence of a
canonical nucleosome over the UAS (see also Fig. 10A and reference
24). Moreover, the core promoter is assembled into
an MNase-resistant structure spanning ~170 bp (
111 to +60; see
schematic), whose precise nature, given its hypersensitivity to DNase I
(25, 64), is unclear. A dramatically different cleavage
profile is seen with hsp82-
HSE1 · , an allele of
HSP82 bearing a 32-bp substitution of the UAS
(24). MNase cleavage is suppressed over much of the upstream
promoter, restricted to two foci centered at
310 and
135 (Fig. 2B).
These chromatin-specific cleavages are consistent with the presence of
linkers flanking a novel, translationally positioned nucleosome (Nuc
2; see schematic). Notably, the cut sites are spaced at intervals of
~10 nt, suggesting that Nuc
2 adopts several, equally preferred
phasing frames. Alternatively, the 10-nt periodicity of cleavage may
arise from the exonuclease activity of MNase (12). Assuming
multiple phasing frames, the inferred dyad axes (
238,
227,
217,
and
207) of Nuc
2 overlap HSE2 and HSE3 (which span
229 to
188
[18]). The core promoter-associated nucleosome (Nuc
1) may also adopt more than one translational setting, as indicated.
Analysis of the 32-bp deletion allele (
HSE1 [Fig. 2C]) suggests
the presence of two similarly positioned nucleosomes, each occupying
multiple phasing frames. As above, the dyad axes of the four principal phasing frames of Nuc
2 overlap HSE2 and HSE3, which in this allele
span
197 to
156. Thus, in both substitution and deletion mutants,
the dyad axis of Nuc
2 overlaps or is in close proximity to HSE2 and
HSE3.


View larger version (108K):
[in this window]
[in a new window]
|
FIG. 2.
MNase genomic footprinting reveals that the promoter
region of hsp82 alleles lacking HSE1 is assembled into a
novel dinucleosome. Illustrated are strand-specific genomic footprints
for HSP82+, hsp82- HSE1 · (a
32-bp substitution mutant), and hsp82- HSE1 (a 32-bp
deletion mutant) (A to C, Chr lanes). Cells were cultivated at 30°C,
nuclei were purified and digested with MNase, and genomic DNA was
isolated. For the naked DNA controls (DNA), genomic DNA was isolated
from each strain and digested with MNase. Each digestion series
represents a set of twofold serial dilutions. Cut sites were mapped by
linear PCR using both upper-strand- and lower-strand-specific primers
(+26 11 and 342 315, respectively). Cleavage profiles were
visualized using a PhosphorImager, and intensities of all major cut
sites were quantitated. They are schematically illustrated below each
set of footprints, with line lengths proportionate to cleavage
intensities. Not all data summarized in the schematics are from the
portions of the gels shown. Ovals, inferred translational positions of
nucleosomes; dashed rectangle, an MNase-resistant, DNase
I-hypersensitive structure. HindIII designations pertain
to the nuclear accessibility assay of Fig. 10. The
HindIII site is at 274 in the WT allele and at 242
in the deletion allele.
|
|
The null transcription phenotype of
HSE1 can be suppressed by
overexpression of HSF.
To investigate whether overexpressed HSF
could rescue the null transcription phenotype of
hsp82-
HSE1, we transformed a strain bearing this allele
with a galactose-inducible HSF1 gene (creating strain CBY101
[Table 1]). Consistent with previous observations (24),
addition of galactose results in a striking increase (25- to 30-fold)
in heat-shocked HSP82 transcript levels, paralleling a
similar increase in intracellular HSF levels (data not shown; see
below). Only cells harboring the GAL1-HSF1 plasmid
experienced this activation, indicating that HSF
and not the product
of some other galactose-induced gene
was responsible. These results
are consistent with the possibility that HSF binds the nucleosomal HSEs. Nonetheless, an extended, degenerate HSE centered at
640 (HSE4
[Fig. 1]) might facilitate HSF-mediated suppression of the
HSE1
null phenotype since (i) overproduction of HSF results in the occupancy
of HSE4, which resides within a DNase I-hypersensitive region
(24); and (ii) HSF binds its target HSEs cooperatively, both
in vitro and in vivo (2, 9, 18). Thus, HSF binding at HSE2
and HSE3 might be cooperative with its occupancy at HSE4. To address
this possibility, we created an allele bearing both a substitution of
HSE1 and a deletion of HSE4 (hsp82-
HSE1 · 4 [Fig.
1]). As indicated by MNase nucleotide resolution mapping (data not
shown), the promoter of this allele is packaged into a chromatin
structure very similar to that inferred for
hsp82-
HSE1 · (Fig. 2B). A strain containing this
allele was transformed with GAL1-HSF1, creating CBY107. This
strain was then subjected to a galactose shift. The heat-shocked
hsp82-
HSE1 · 4 gene, similar to
hsp82-
HSE1, is effectively activated by HSF, with
transcript levels significantly increasing (5- to 10-fold) over a 5-h
time course (data not shown; see below). We conclude that overexpressed HSF can restore function exclusively through its interaction with the nucleosomal HSEs.
Prior arrest in G1 blocks HSF-mediated suppression of
the
HSE1 null phenotype.
The ability of HSF to bind HSE2 and
HSE3 allowed us to investigate the mechanism by which the protein
accesses nucleosomal sites. If HSF invades Nuc
2 and directly binds
its target sequences, then its binding to nucleosomal DNA would be cell
cycle independent. Alternatively, HSF might preempt the assembly of Nuc
2, either by binding DNA immediately following replication, when
histone octamers are transiently displaced from the newly synthesized DNA (13, 32, 63; but see reference
8), or by binding to the nascent nucleosome shortly
thereafter, aborting its maturation. Either way, such binding would be
cell cycle dependent. More complex mechanisms are also possible. To
gain insight into the HSF-Nuc
2 interaction, CBY101 cells were
arrested in G1 with the mating pheromone,
-factor.
Following a 2.5-h incubation in the presence of
-factor, >95% of
CBY101 cells were arrested in G1, as assayed by microscopy.
At this point, galactose was added directly to the medium to a final
concentration of 1%, and aliquots were removed at various times and
heat shocked (protocol summarized in Fig. 3A). As shown in Fig. 3B, HSF-mediated
activation is virtually eliminated in G1-arrested cells,
even though HSF overexpression is unaffected by a prior G1
arrest (Fig. 3E). Nonetheless, a modest increase in hsp82
transcription is detected. Such activation could stem from HSF
interacting with HSE2 and -3 at reduced efficiency in
G1-arrested cells, perhaps by binding to Nuc
2 in certain phasing frames but not in others. Alternatively, it could be a consequence of HSF binding to the accessible, far-upstream HSE4. To
help distinguish between these possibilities, we subjected the
HSE4-deleted strain CBY107 to a similar protocol. As can be seen in
Fig. 3C, induced HSP82 transcript levels do not increase in
G1-arrested hsp82-
HSE1 · 4 cells
following addition of galactose, whereas substantial activation of the
gene takes place in the parallel, asynchronous culture. Therefore, the
slight increase in hsp82-
HSE1 transcription following
long periods of galactose induction in G1-arrested cells is
likely due to HSF binding to HSE4.

View larger version (40K):
[in this window]
[in a new window]
|
FIG. 3.
Transactivation of hsp82- HSE1 is blocked
during G1 arrest. (A) Experimental strategy. Cells pregrown
to early log phase in the presence of 2% raffinose were arrested in
G1 by addition of -factor. Following a 2.5-h incubation
at 30°C, >95% of the cells were unbudded shmoos, indicative of
G1 arrest. At that point (t = 0 h),
galactose was added, and at the indicated times aliquots were
heat-shocked and RNA was isolated. (B) HSP82 transcript
levels in asynchronous and G1-arrested CBY101 cells
subjected to galactose shift for the times indicated. (C) Same as panel
B except that strain CBY107 was used. (D) HSP26 transcript
levels in CBY101 cells, assayed from the RNA samples of panel B. (E)
Immunoblot analysis. Total protein was isolated from asynchronous ( )
and G1-arrested (+) CBY101 cells, electrophoretically
separated on an SDS-10% polyacrylamide gel, blotted to
nitrocellulose, and sequentially probed with anti-HSF and anti-Leu4p
antibodies. HSF levels, quantitated on a Storm PhosphorImager, are
normalized with respect to Leu4p. Data depicted in panels B to D are
from representative experiments; the trends shown were found to be
highly reproducible (five independent experiments for panel B, three
for panel C, and two for panel D).
|
|
One explanation for the impaired activation of hsp82 is that
HSF is functionally compromised during G1. However, as
revealed by rehybridization of the Northern blot in Fig. 3B,
transcriptional induction of a second HSF-regulated gene,
HSP26, is unaffected by pretreatment with
-factor: its
transcript levels increase 40- to 50-fold during a 15-min heat shock
irrespective of the extent of HSF overexpression, indistinguishable
from the parallel, asynchronous culture (Fig. 3D). A potentially
significant difference between hsp82-
HSE1 and
HSP26 is that the HSEs of the latter reside within
accessible, DNase I-hypersensitive sites (10; D. Pederson, personal communication). Thus it is possible that in
G1-arrested cells, HSF is incapable of activating a
nucleosomal promoter while exhibiting full activity at a second,
accessible one. Indeed, heat shock induction of
HSP82+, like that of HSP26, is
unaffected by a prior arrest in G1 (data not shown).
Prior G1 arrest blocks HSF binding to Nuc
2.
While HSF is unable to activate transcription of the
hsp82-
HSE1 allele during G1, it is not clear
whether this block is at the level of HSF binding or at a subsequent
step in the transcription pathway. To help clarify this, we used DMS in
vivo footprinting. Previous work has demonstrated that HSF inducibly
binds HSE2 and HSE3 within the WT promoter, with the signature of its
interaction being hyperreactivity of guanine
210 (18, 23).
We therefore subjected asynchronous and G1-arrested CBY101
cultures to a 3-h galactose shift and then heat shocked cells for 15 min at 39°C. During the final 2 min, protein-DNA interactions were
probed with DMS; genomic DNA was then isolated to permit mapping of
methylated sites. Following incubation in the presence of galactose,
HSF binding to the nucleosomal HSEs is readily detectable in
asynchronous cells (Fig. 4). Similar but
less robust binding is evident at the activated
hsp82-
HSE1 · 4 promoter (see Fig. 8), paralleling its lower expression level. There is no detectable
210 G
hyperreactivity in non-heat-shocked cells (data not shown; see also
Fig. 8B), indicating that virtually all binding to HSE2 and HSE3 occurs upon heat shock, as is the case for the WT promoter. In contrast to the
asynchronous cultures, the G1-arrested culture is largely refractory to activated HSF binding (Fig. 4A, lane 7 versus lane 5;
Fig. 4B, 3-h scans, asynchronous versus G1 arrested),
despite attaining comparable HSF levels (Fig. 3E). The slight increase in modification of
210 G during the 3-h galactose shift is most likely due to cells escaping from G1 arrest and/or a low
level of nucleosomal binding facilitated by cooperative interactions with HSF bound to the accessible HSE4 site. We conclude that the G1-induced block in HSF activity is at the level of HSF
binding to nucleosomal DNA.

View larger version (25K):
[in this window]
[in a new window]
|
FIG. 4.
In vivo DMS footprinting analysis of the heat shock UAS
of hsp82- HSE1 in asynchronous and G1-arrested
CBY101 cells. (A) Early-log-phase cultures grown in 2% raffinose were
arrested in G1 (+ -factor) or left untreated
( -factor). Galactose was then added to a final concentration of
1% to induce HSF overexpression. Following a 2-h incubation, the
arrested culture was washed; one half was resuspended into medium
containing pheromone (+ -factor), the remaining half was resuspended
in medium alone (washout [w/o]), and the incubation continued for an
additional hour. Aliquots were removed, heat shocked, and reacted with
DMS. Genomic DNA was isolated and subjected to linear PCR using the
+26 11 primer, detecting the upper-strand methylation pattern. The
210 G, whose reactivity is diagnostic of bound HSF (18,
23), is indicated. DNA, deproteinized genomic DNA methylated in
vitro and analyzed as above; A and G, dideoxy sequencing ladders. (B)
Densitometric analysis of the data presented in panel A. Amplitudes are
normalized to that of 219 G. 3*, 3-h galactose-shifted sample washed
free of -factor during the final hour.
|
|
Washout of
-factor relieves the transcriptional block.
If
replication (or some other S-phase-associated event) were required for
HSF to access HSE2 and HSE3, then release from
-factor-induced-arrest should restore HSF's ability to
transactivate the mutant alleles. To test this idea, cells bearing the
HSE1 deletion were arrested in G1 with
-factor as
described above. Following a 1.5-h incubation in the presence of
galactose, the arrested culture was split into two aliquots. One was
washed and resuspended in galactose-containing medium lacking
-factor, while the other was washed and resuspended in medium
containing
-factor (experimental strategy summarized in Fig.
5A). Consistent with the above
prediction, within 60 to 120 min of washout (i.e., as soon as budded
cells were visible), induced transcript levels in the released culture
were substantially increased (Fig. 5B). Paralleling this increase is
significant binding of HSF to HSE2 and HSE3, as monitored by
210
hyperreactivity (Fig. 4A, lane 8; Fig. 4B, scan 3*). Importantly, the
potentiating effect of releasing cells from G1 arrest
cannot be explained by an alteration in intracellular HSF levels (Fig.
5C). These results thus indicate that HSF binding to and
transactivation of hsp82-
HSE1 requires relief from the
G1 block.

View larger version (22K):
[in this window]
[in a new window]
|
FIG. 5.
Release from G1 arrest alleviates the
transcriptional block at hsp82- HSE1. (A) Experimental
strategy. CBY101 cells were arrested in G1 as for Fig. 3;
an asynchronous culture (not indicated) was grown in parallel. At
t = 0 h, galactose was added to each culture to induce
HSF overexpression. At t = 1.5 h, the
-factor-arrested culture was split into three aliquots; one was
washed and resuspended into medium lacking -factor, one was washed
and resuspended into medium containing -factor, and the third was
washed and resuspended into medium containing HU. The asynchronous
culture was also harvested and resuspended into medium alone. Samples
were removed at the indicated times and subjected to heat shock. (B)
Plot of Northern data from the experiment depicted in panel A. (C)
Immunoblot analysis. Total protein was isolated from aliquots of CBY101
cells subjected to the indicated treatments and harvested at the
indicated times and then assayed for relative HSF concentration.
|
|
hsp82-
HSE1 is reactivated during early S phase.
To define more precisely at which point in the cell cycle HSF can
activate hsp82-
HSE1, HU, an inhibitor of ribonucleotide reductase (16), was used to block cells in early S phase
following their release from G1 arrest. The experimental
strategy used is similar to that described above (Fig. 5A). Northern
analysis shows that cells released into HU are induced to levels
similar to those of either the asynchronous culture or the
-factor-arrested culture released into medium alone (Fig. 5B).
Moreover, as above, HSF levels in such cells are virtually identical to
those seen in the parallel,
-factor-arrested cells (Fig. 5C). Taken
together, these results indicate that an early S-phase event is both
necessary and sufficient for HSF to transactivate the nucleosomal promoter.
Prior arrest in early S phase potentiates the nucleosomal heat
shock promoter for transactivation.
An implication of the above is
that cells which transit from late G1 (Start) to a point in
early S phase are permissive to HSF transactivation. To determine
whether asynchronous cells treated with HU are similarly permissive,
and to extend the analysis to the hsp82-
HSE1 · 4 allele, we arrested CBY107 cells with HU prior to inducing HSF
overexpression. Inhibition of DNA replication was confirmed by FACS
analysis of propidium iodide-stained cells (see Materials and Methods).
Galactose was then added to induce HSF overexpression, and aliquots
were removed and heat shocked at various times thereafter. Quite
strikingly, hsp82 transcription is strongly activated in
cells synchronized in S phase, even in the absence of galactose
induction (Fig. 6). Following galactose shift, a further increase in HSP82 transcription is seen.
These data suggest that activated HSF efficiently binds nucleosomal HSEs during early S phase. The possibility that the enhanced
transcription seen in the treated cultures is due to HU induction of
hsp82 beyond that elicited by heat shock is unlikely, since
addition of HU to noninduced CBY107 cells does not discernibly increase
hsp82 transcript levels (data not shown). Moreover, HSF
protein levels are induced to similar levels in asynchronous and
HU-arrested cells (data not shown; Fig. 5C). Taken together, these data
implicate an event in early S phase as potentiating HSF activation of
the nucleosomal promoter.

View larger version (28K):
[in this window]
[in a new window]
|
FIG. 6.
Prior arrest in S phase potentiates transcriptional
activation of the hsp82- HSE1 · 4 promoter. CBY107
cells pregrown in 2% raffinose-containing medium were arrested in S
phase by incubation in the presence of 200 mM HU for 2.5 h.
Galactose was added to the arrested culture and to a parallel
asynchronous culture, and aliquots were removed at the indicated times
for heat shock and subsequent RNA analysis. Depicted are mean values of
three independent Northern analyses (normalized to the 0-h asynchronous
sample; bars indicate standard error of the mean).
|
|
HSF efficiently activates hsp82-
HSE1 in
G2/M-arrested cells.
To extend the above findings, we
tested whether HSF could transactivate hsp82-
HSE1 at a
later point in the cell cycle. We used nocodazole, an inhibitor of
microtubule assembly (53), which imposes a synchronous
arrest in late G2/early M. Given the short G2
phase in yeast (41), activation of the nucleosomal promoter
might be anticipated if nucleosome maturation is regulated and, as
previously observed in metazoans (59, 70), proceeds over an
extended period of time. On the other hand, as chromatin condensation
is maximal during mitosis (26), HSF binding to a stable
nucleosome might be severely impaired. Indeed, in vivo DMS footprints
of sequence-specific activators are erased at a variety of mammalian
promoters during metaphase (28, 44, 47).
To effect a G2/M arrest, nocodazole was added to
logarithmically growing CBY101 cells, which were allowed to incubate in
its presence for 3.5 h. Addition of drug, but not of vehicle
alone, resulted in the arrest of >95% of cells, as assayed by
microscopic examination of cell morphology (Fig.
7A). Following either a 1.5- or 3.5-h
galactose shift, hsp82-
HSE1 activation in
G2/M-arrested cells occurs at levels indistinguishable from
the asynchronous control (Fig. 7B), correlating with the respective
levels of HSF overexpression (Fig. 7C). Also unaffected is HSF binding:
reactivity of
210 G in response to heat shock is equally robust in
asynchronous cultures and those prearrested in G2/M (Fig.
7D). Identical results were seen with the HSE double mutant,
hsp82-
HSE1 · 4, since neither transcriptional
activation nor HSF binding was affected by prearresting cells in
G2/M phase (Fig. 8). The
latter data indicate that HSF is capable of binding the nucleosomal
elements independently of HSE4. They also show that even when
overexpressed, HSF binding to HSE2 and HSE3 and transactivation of
hsp82 is detectable only upon heat shock (Fig. 8A, compare
lanes 7 and 8 with lanes 3 to 6; Fig. 8B, compare scan
5.5NHS with scan 5.5). We conclude that the ability of HSF
to bind nucleosomal DNA and transactivate either
hsp82-
HSE1 or hsp82-
HSE1 · 4 is not
restricted to early S phase but rather extends to at least late
G2/early M.

View larger version (47K):
[in this window]
[in a new window]
|
FIG. 7.
HSF activation of hsp82- HSE1 is not
affected by prior arrest in G2/M. (A) Cell morphology of
asynchronous and G2/M-arrested CBY101 cells. Cells grown to
early log phase in 2% raffinose (upper left) were split into two
aliquots. Nocodazole was added to one; vehicle alone (DMSO) was added
to the other. Following incubation for 3.5 h at 30°C, >95% of
cells in the nocodazole-treated culture had arrested with large buds
(lower left), while the mock-treated culture contained ~25%
large-budded cells (upper right). Galactose was then added to a final
concentration of 1%, and cells were allowed to incubate for a further
1.5 h (lower right). (B) Northern analysis of asynchronous ( )
and G2/M-arrested (+) CBY101 cells subjected to heat shock
following a 0-, 1.5-, or 3.5-h galactose shift. Transcript levels of
HSP82 and the internal loading control, ACT1,
were detected by blot hybridization. (C) Immunoblot analysis. Total
protein was isolated from samples depicted in panel B, and sequential
detection of HSF and Leu4p was performed as before. (D) DMS in vivo
footprinting analysis. Cells from the cultures analyzed in panel B were
reacted with DMS, DNA was purified, and the presence of methylated
guanines was detected as described for Fig. 4.
|
|

View larger version (27K):
[in this window]
[in a new window]
|
FIG. 8.
HSF activation of hsp82- HSE1 · 4 is
not affected by prior arrest in G2/M. (A) Northern analysis
of asynchronous ( ) and G2/M-arrested (+) CBY107 cells
subjected to a 15-min heat shock (lanes 1 to 6) or maintained under
non-heat shock conditions (NHS; lanes 7 and 8) following a 0-, 3.5-, or
5.5-h galactose shift. (B) DMS in vivo footprinting analysis. Cells
from the heat-shocked cultures analyzed in panel A were reacted with
DMS, and the DNA was purified. The presence of methylated guanines was
detected as for Fig. 4; scans of the pertinent region of the sequencing
gel are shown. 5.5NHS, nocodazole arrested, 5.5-h galactose
shifted, non-heat-shocked culture. DNA, genomic DNA isolated from
CBY107 and reacted with DMS and analyzed as above.
|
|
Activation of hsp82-
HSE1 is uncoupled from its
replication.
The foregoing experiments demonstrate that cells
which transit from late G1 to a point in early S phase are
permissive to HSF binding and transactivation. One mechanism that could
account for this is DNA replication. In eukaryotes, the temporal order in which genes are replicated during each S phase is preset (20, 21); therefore, it is possible that hsp82 is
replicated early, prior to the HU block. To investigate this
possibility, we used quantitative Southern blotting. The DNA content of
hsp82-
HSE1 was measured with respect to that of a
chromosomal reporter gene (Kanr) excised during
G1 arrest as a nonreplicating DNA ring (see Materials and
Methods). A strain bearing both the hsp82-
HSE1 and
Kanr alleles was arrested in G1
using
-factor as above, then a GAL1-R-recombinase gene
fusion was induced through addition of galactose. Following a 3.5-h
galactose shift, virtually complete excision of
Kanr is achieved (Fig.
9A, lane 2 versus 1). Cells released from
G1 arrest and resuspended into medium alone replicate
hsp82, but not Kanr, as expected,
with the hsp82/Kanr ratio nearly
doubling within 120 min and tripling within 180 min (Fig. 9A, lanes 10 and 11; mean values from four independent experiments are graphically
illustrated in Fig. 9B). In contrast, there is no increase in the
hsp82/Kanr ratio in cells maintained
in the presence of
-factor (Fig. 9A, lanes 3 to 5; Fig. 9B), as
expected. Importantly, cells subjected to a subsequent HU arrest also
show no increase in relative hsp82 DNA content (Fig. 9A,
lanes 6 to 8) since hsp82/Kanr ratios
are statistically indistinguishable from those obtained for the
G1-arrested samples (Fig. 9B). This observation argues against DNA replication being the S-phase requirement for HSF binding
and transactivation of hsp82-
HSE1.

View larger version (43K):
[in this window]
[in a new window]
|
FIG. 9.
The hsp82- HSE1 locus is not detectably
replicated between late G1 (Start) and early S phase, as
revealed by Southern blot hybridization. (A) CBY120 cells (Table 1)
growing in the presence of 2% raffinose were arrested in
G1 with -factor (lane 1). Galactose was then added for
3.5 h, and cells were harvested (lane 2). One third of the cell
pellet was resuspended in 2% glucose medium containing -factor, one
third was resuspended in glucose medium containing HU, and one third
was resuspended in glucose medium alone (no drug). At the indicated
times, cells were harvested. DNA was then purified and digested to
completion with EcoO109I, and 1.5 µg was separated on a
1% agarose gel, blotted to nylon, and simultaneously hybridized with
probes specific for the hsp82 and
Kanr loci. Radioactivity was detected using a
Storm PhosphorImager; bands corresponding to the EcoO109I
fragments of hsp82 (4.5 kb) and the
Kanr excised ring (2.9 kb) were quantitated
using ImageQuant 3.3. *, band which cross-hybridizes to the
HSP82 riboprobe. M, molecular weight standard
(HindIII-cut DNA). Note that equivalent amounts of
DNA were loaded in all lanes; thus, the nonreplicating
Kanr sequence is diluted in growing cells (lanes
10 and 11). (B) Bar graph summary of
hsp82/Kanr quotients from four
independent experiments. Presented are means ± standard error of
the means, with values normalized to -factor 1-h samples.
|
|
Integrity of Nuc
2 persists in G1-, early S-, and
G2/M-arrested cells.
An alternative explanation for
the cell cycle-specific binding of HSF is that alterations in chromatin
structure occur at Nuc
2 which impair HSF binding to HSE2 and HSE3 at
one point in the cell cycle (late G1) while enhancing it at
another (early S phase). To test this idea, we measured accessibility
of Nuc
2 in nuclei isolated from asynchronous
hsp82-
HSE1 cells or cells arrested in late
G1, early S, or G2/M. Following purification from spheroplasts, nuclei were digested with HindIII,
whose recognition site (position
242 at hsp82-
HSE1
[Fig. 2C]) lies within the mapped location of Nuc
2. As expected,
the HindIII site is largely inaccessible in nuclei
isolated from noninduced, nonoverexpressing BSY202 cells (3 to 5%
cleavage versus 20 to 30% cleavage in WT nuclei [Fig.
10A]). A similar, low level of
accessibility is seen in
HSE1 nuclei isolated from noninduced cells
arrested in late G1, early S, or G2/M (Fig.
10B). Therefore, the basic integrity of Nuc
2 is retained during
these phases of the cell cycle and cannot, by itself, account for the
cell cycle-specific phenomena described above. These results are
consistent with those of the quantitative Southern analysis; both argue
that enhanced HSF binding and transactivation of
hsp82-
HSE1 occur independently of its replication and
attendant chromatin disassembly.

View larger version (51K):
[in this window]
[in a new window]
|
FIG. 10.
The HindIII site is virtually
inaccessible within the hsp82- HSE1 promoter in both
asynchronous and cell cycle-arrested cells. (A) Asynchronous SLY101
(WT) and BSY202 ( HSE1) cells were grown at 30°C in complete
synthetic medium supplemented with 2% raffinose. Nuclei, isolated from
spheroplasts and quantitated as previously described (17),
were digested with either 12 or 40 U of HindIII per µg
of DNA at 30°C for 60 min. Genomic DNA was purified, digested to
completion with MspI, and subjected to linear PCR using the
+26 11 primer, and the amplified products were electrophoresed on
an 8% sequencing gel. Bands were detected and quantitated using a
PhosphorImager. Percent accessibility was calculated by dividing
the total signal present in the daughter (D) fragment (resulting from
HindIII cleavage) by that present in the sum of the
parental (P) fragment plus daughter fragment. (B) As in panel A except
that BSY202 cells were either maintained in log growth (async.) or
arrested at the indicated phases in the cell cycle prior to isolation
of nuclei. Samples were digested with 40 U of
HindIII per µg of DNA and processed as above. See Fig.
2 for location of HindIII site with respect to mapped
chromatin structure.
|
|
 |
DISCUSSION |
HSF binds nucleosomal HSEs in a cell cycle-dependent fashion.
Using a combination of in vivo footprinting and RNA expression
analysis, we have obtained compelling evidence that S. cerevisiae HSF binds nucleosomal HSEs, and transactivates the
linked gene, in a cell cycle-dependent fashion. To demonstrate this, we
have used the hsp82-
HSE1 gene, whose promoter is
assembled into a stable dinucleosome, as our model system. The ability
of HSF to access HSE2 and HSE3 is dependent on the protein being (i)
overexpressed and (ii) activated by heat shock, which enhances its
intrinsic DNA binding activity 10- to 25-fold (18, 23).
These two requirements are consistent with previous in vitro binding
competition assays which indicate that the overall affinity of the
hsp82-
HSE1 promoter for HSF is <4% that of the WT
promoter (18). They have also provided us with a means to
assay HSF binding at precisely defined points during the cell cycle.
Using this approach, we have found that HSF binding to nucleosomal HSEs
and concomitant transcriptional activation of hsp82-
HSE1 is greatly impaired in cells prearrested in late G1.
However, factor binding and activation of hsp82-
HSE1 are
restored following release of cells from the G1 block, even
when such cells are subsequently arrested in early S phase. Indeed,
prearresting cells in early S actually potentiates
hsp82-
HSE1 for transcriptional activation, implying that
HSF binds nucleosomal HSEs with increased efficiency in early S (see
below). Cells prearrested in late G2/early M are neither
suppressed nor enhanced for HSF binding and transactivation.
It is possible that the G1 block in HSF activity stems from
an
-factor-specific effect. However, we have found that addition of
-factor to cells prearrested in G2/M has no effect on
the capacity of subsequently overexpressed HSF to suppress the
HSE1 null phenotype (data not shown). In light of previous work indicating that
-factor is capable of eliciting a normal signal transduction cascade in nocodazole-arrested cells (49), an
-factor-specific effect is unlikely to explain the G1
block in HSF binding.
Cell cycle-dependent binding by HSF to a defined nucleosomal site
represents, to the best of our knowledge, the first demonstration of
such behavior by a transcriptional activator. In particular, HSF
provides a striking contrast to GAL4 and Bicoid, which are able to bind
to well-defined nucleosomal sites in G1-arrested S. cerevisiae cells (6) and to nuclear hormone receptors
and NF-
B, which appear capable of binding target nucleosomal sites in vertebrate cells irrespective of the phase of the cell cycle (55, 67, 69). Similar to the case for HSF, cell
cycle-dependent binding by yeast PPR1 has been inferred from genetic
studies of a telomere-linked URA3 allele. These showed that
conditionally overexpressed PPR1 could transactivate
URA3-TEL in cells prearrested in G2/M but not in
cells prearrested in G1, early S, or G0
(4). The chromatin structure of the URA3-TEL
promoter is unknown; nevertheless, it is probable that this structure
undergoes disassembly during DNA replication, which may account for its
accessibility in cells blocked in G2/M.
Is DNA replication required for HSF binding to nucleosomal
sites?
Using quantitative Southern blotting, we have tested
whether HSP82 is replicated between its release from
-factor-induced arrest in G1 and its subsequent
HU-induced arrest in S phase. We have found that HSP82 DNA
content remains constant with respect to both a very late replicating
locus, KEX2 (20) (data not shown) and a reporter
gene excised during G1 arrest as a nonreplicating DNA ring
using an inducible site-specific recombinase system (Fig. 9). While we
cannot rule out a small (<20%) increase in hsp82 DNA
content between Start and HU arrest, we can rule out a doubling of gene
copy number. Consistent with the idea that replication is unnecessary
for restoring HSF binding activity, enhanced DMS reactivity of the
210 G residue, diagnostic of the HSF-HSE2/3 interaction, is seen
within 1 h of release from
-factor arrest, a time when
replication has yet to be detected in cells resuspended in medium
alone. Also arguing against replication is that the integrity of Nuc
2, as assayed by its accessibility to HindIII, persists through the HU block. Thus, HSF binding to Nuc
2 is most
likely replication independent. The temporal uncoupling of DNA
replication from HSF binding argues for a more complex mechanism than
the simple disruption, preempt, or exclusion models discussed earlier.
HSF might use aspects of all three, with the operative mechanism
dependent on the phase of the cell cycle. A summary of our findings is
presented in Fig. 11.

View larger version (28K):
[in this window]
[in a new window]
|
FIG. 11.
HSF binding and transactivation of a nucleosomal
regulatory site as a function of the cell cycle: summary of Northern,
DNA footprinting, and Southern data. Restriction to HSF
binding/transactivation is indicated by a filled rectangle; points
which are permissive are indicated by open rectangles. The window of
opportunity for HSF binding and transactivation could extend beyond the
G2/M transition but has not yet been examined. As
indicated, replication of hsp82 occurs subsequent to the HU
block (see text). The relative lengths of each cell cycle phase have
not been determined for the strains used in this study and represent an
approximation only.
|
|
If replication is unlikely to account for the cell cycle-dependent
binding of HSF to HSE2 and -3, what can? One possibility is that HSF
itself is cell cycle regulated. However, since HSF's ability to bind
accessible promoters during late G1 is not impaired
as implied by its efficient induction of either HSP26 (Fig. 3)
or HSP82+ (data not shown)
such a
G1-specific defect would be restricted to nucleosomal
target sequences. Alternatively, a coactivator of HSF might be cell
cycle regulated, inactive during G1, and reactivated
following entry into S phase. Indeed, activity of the human SWI/SNF
remodeling complex is cell cycle regulated (57); however, in
this case, transitional inactivation and reactivation occur in
G2/M and G1, respectively. Relevant to this, in
experiments to be reported elsewhere, we find that nuclei isolated from
early S-phase-arrested, heat-shocked BSY202 cells show a pronounced (three- to fivefold) increase in HindIII accessibility
over that seen in non-heat-shocked cells. No significant increase in
accessibility is seen in nuclei isolated from heat-shocked,
asynchronous cells or from those arrested in other points of the cell
cycle (data not shown). These observations parallel the expression
data; together they indicate that HSF binds, remodels, and
transactivates the nucleosomal promoter most efficiently during early S
phase. Thus a coactivator with which HSF associates could be regulated
such that it is maximally active or abundant during this point in the cell cycle. Alternatively, an S-phase-specific event might globally prepare chromatin for replication (37); activated HSF might exploit this remodeled state to bind and perturb Nuc
2. Current experiments are addressing these and other possibilities.
Therefore, an appealing scenario is that the hsp82
dinucleosome is remodeled by a histone acetyltransferase or
ATP-dependent remodeling complex following release of cells from
-factor arrest, facilitating HSF binding and transactivation of
hsp82-
HSE1. Consistent with this, Drosophila
HSF is greatly benefited by histone acetylation in binding to an in
vitro-reconstituted chromatin template, much more so than other
activators (48). This might be a consequence of the fact
that HSF binds DNA as a homotrimer (52, 60), occupying both
faces of the DNA helix (42). Thus, for the protein to bind a
nucleosomal site, particularly one proximate to the dyad, a substantial
change in free energy is likely necessary to disengage the double helix
from its contacts with the histone octamer (54). This
process could be facilitated by acetylation (39, 68) or
ATP-dependent nucleosomal remodeling (11, 38). While such a
requirement may not be as stringent in situations where the target HSEs
are positioned near the edge of a nucleosome, it is noteworthy that
only specific rotational variants are permissive to HSF binding in vivo
(22, 51).
The HSF-nucleosome interaction: paradigm for cell
differentiation-specific regulators.
DNA binding by
transcriptional activators is normally an essential, early step in the
activation of gene expression. The current paradigm for
activator-chromatin interactions posits that either transcription
factors possess an inherent ability to invade a preassembled nucleosome
and directly bind their cognate sites (at least in a milieu rich in
chromatin remodeling activity such as the eukaryotic nucleus) or their
binding sites reside within nucleosome-free regions. In either case,
when an activator is present, its binding occurs irrespective of the
stage of the cell cycle. Supporting this notion, a variety of
transcription factors are able to bind nucleosomal sites in a cell
cycle-independent fashion (6, 55, 67, 69, 74). Here we have
provided evidence for a distinctly different mechanism, one in which
the nucleosome per se dictates cell cycle-dependent binding of a
gene-specific activator. The HSFNuc
2 interaction may therefore
serve as an alternative paradigm for those transcriptional activators
which are unable to access their target DNA binding sites when such sites are assembled into stable nucleosomes. This property would prevent genes bearing regulatory sites from being inappropriately activated in G1-phase cells expressing the cognate
activator. Cell cycle-dependent gene activation could be integral to
such processes as cell differentiation, where a gene-specific activator could theoretically gain access to its target regulatory sites during a
"quantal" cell division (31).
It is possible that this cell cycle-dependent mechanism is in fact
never used by HSF in the regulation of HSP82+ or
other stress-responsive genes in S. cerevisiae. However,
three considerations suggest otherwise. First, the intrinsic state of the HSP82 promoter is dinucleosomal. This structure not only
forms in vivo at hsp82 alleles lacking HSE1 but is readily
reconstituted over the WT promoter in vitro (A. M. Erkine and
D. S. Gross, unpublished results). Second, yeast HSF, similar to
human HSF (65), is incapable of binding even high-affinity
sites assembled within stable nucleosomes in vitro (Erkine and Gross,
unpublished). Thus, while it is possible that HSF can invade a
G1-phase nucleosome bearing a high-affinity site, the
inability of HSF to exhibit such activity in vitro, coupled with the
inability of overexpressed HSF to bind low-affinity nucleosomal sites
in vivo, argues otherwise. Finally, unlike its metazoan counterpart,
yeast HSF constitutively binds high-affinity HSEs. This constitutive
binding is responsible not only for maintaining target promoters in an
open chromatin configuration (17, 24) but also for driving
basal transcription (46, 50). It is thus probable that HSF
binds to target promoters soon after they have replicated, well within
the S/G2 window observed here. The breadth of the window
could reflect the fact that immature nucleosomes (comprised of
acetylated H3-H4 tetramers or octamers [3]) are more
accessible to transactivators than mature nucleosomes comprised of
unacetylated octamers.
We thank Mike Hampsey, Ned Sekinger, and Harpreet Singh for
comments on the manuscript and acknowledge Walton Fangman, David Hagen,
Gunter Kohlhaw, M. K. Raghuraman, Peter Sorger, George Sprague,
and Bruce Stentz for gifts of antibodies, strains, and plasmids.
This work was supported by grants to D.S.G. from the National Institute
of General Medical Sciences (GM45842), the American Cancer Society,
Inc. (NP-945), and the Center for Excellence in Cancer Research at
LSUMC-Shreveport.